- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Alzheimer's Research Strategy Announced
18 May 2012 4:50 pm
An international panel of experts released recommendations today for future research on Alzheimer's disease. The recommendations will help guide the research component of the new national plan for Alzheimer's disease announced Tuesday by Health and Human Services Secretary Kathleen Sebelius. The plan sets the ambitious goal of developing effective prevention and treatment strategies for Alzheimer's by 2025.
The new research strategy was developed by experts who met during a 2-day summit at the U.S. National Institutes of Health (NIH) in Bethesda, Maryland, earlier this week. The panel acknowledges a number of challenges facing the field, including the need to develop better experimental models and to initiate clinical trials at earlier stages of the disease. Their recommendations include conducting more interdisciplinary research on the biological mechanisms of Alzheimer's disease and therapeutic targets, enabling more rapid and extensive sharing of data and biological specimens, and fostering more public-private partnerships (along the lines of the Alzheimer's Disease Neuroimaging Initiative, a successful biomarker development effort jointly funded by NIH and the pharmaceutical industry). The panel also calls for more research on nondrug interventions, such as lifestyle changes, that might prevent or slow the disease.
A financial stimulus for Alzheimer's research appears to be in the works: President Barack Obama's proposed 2013 budget includes $80 million in new funding. Congress has yet to weigh in on that plan.